NMD4C and Muscular Dystrophy Canada are pleased to invite you to a CPD-accredited webinar on the CMT: Clinical and Research Updates. This CPD-accredited webinar is primarily targeted at Canadian clinicians, academics and trainees with an interest in neuromuscular diseases.

This is an independent clinical/academic webinar with organizational and technical support provided by NMD4C and MDC.

Learning Objectives:

1. Explore current clinical trial design and endpoints for CMT1A studies
2. Review viral and non-viral genetic therapy candidates for CMT1A
3. Discuss EDK060 ongoing clinical trial
4. Describe CMT as a main presentation of primary mitochondrial diseases
5. Examine molecular studies on mitochondrial CMT in iPSC derived motor neurons
6. Evaluate precision therapies in CMT targeting cellular compensatory pathways

The NMD Rounds & Educational Webinars are self-approved group learning activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada. NMD4C and MDC are providing organizational and technical support. This webinar is supported by Novartis through a restricted educational sponsorship with no involvement or influence on program content.

If you have any questions, please contact our Network Manger, Erin Beattie